Moreover, the HLA-B27 aggregated the immune activity of CCR7+/RELB+/IRF1+ T cells, resulting in adverse prognosis for JIA individuals with HLA-B27+. The gene discussed is IRF1; the disease is juvenile idiopathic arthritis.